Monographs

45. CRISPR… ¿debemos poner límites a la edición genética?

Nuevas técnicas de edición genética como el CRISPR/Cas9 abren un abanico de posibilidades en la salud de las personas. Permiten corregir genes defectuosos para curar enfermedades y también mejorar caracteres de futuros individuos o especies animales o vegetales. ¿Quién debe determinar sus usos? ¿Es necesario establecer límites?

Fill out the form below to request the download of the publication. Once your request is submitted, you will receive a download link by email

All fields are required unless otherwise stated

First Name

Last Name

Email Address

I would like to receive future communications from Grifols Foundation (Optional)

Data Protection Information
The Grifols' group company to which you submit the request, as data controller or data owner, will process your personal data to manage your requests. The legal basis is Grifols' legitimate interest, consent or contract execution. Your data may be shared with Grifols' group companies and other third parties mostly providers of products and/or services hired by Grifols. You have the right to access, rectify and erase your personal data. For any other rights and additional information on personal data protection review the Privacy Notice.

recaptcha-check Required

By clicking the button below, I agree that my data will be used as described in this form.